OBESITY REVIEWS[ta] - Search Results

Year	Number of Results
2000	16
2001	27
2002	36
2003	29
2004	32
2005	41
2006	39
2007	116
2008	115
2009	136
2010	117
2011	187
2012	132
2013	138
2014	124
2015	125
2016	132
2017	168
2018	181
2019	195
2020	213
2021	289
2022	166
2023	155
2024	106

1

The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases.

Hariharan R, Odjidja EN, Scott D, Shivappa N, Hébert JR, Hodge A, de Courten B. Hariharan R, et al. Obes Rev. 2022 Jan;23(1):e13349. doi: 10.1111/obr.13349. Epub 2021 Oct 27. Obes Rev. 2022. PMID: 34708499 Review.

2

Human microbiome and metabolic health: An overview of systematic reviews.

Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I. Michels N, et al. Obes Rev. 2022 Apr;23(4):e13409. doi: 10.1111/obr.13409. Epub 2022 Jan 3. Obes Rev. 2022. PMID: 34978141 Review.

3

Economic burden of childhood overweight and obesity: A systematic review and meta-analysis.

Ling J, Chen S, Zahry NR, Kao TA. Ling J, et al. Obes Rev. 2023 Feb;24(2):e13535. doi: 10.1111/obr.13535. Epub 2022 Nov 27. Obes Rev. 2023. PMID: 36437105 Free PMC article. Review.

4

Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials.

Iqbal J, Wu HX, Hu N, Zhou YH, Li L, Xiao F, Wang T, Jiang HL, Xu SN, Huang BL, Zhou HD. Iqbal J, et al. Obes Rev. 2022 Jun;23(6):e13435. doi: 10.1111/obr.13435. Epub 2022 Feb 22. Obes Rev. 2022. PMID: 35194917 Review.

5

Obesity in South and Southeast Asia-A new consensus on care and management.

Tham KW, Abdul Ghani R, Cua SC, Deerochanawong C, Fojas M, Hocking S, Lee J, Nam TQ, Pathan F, Saboo B, Soegondo S, Somasundaram N, Yong AML, Ashkenas J, Webster N, Oldfield B. Tham KW, et al. Obes Rev. 2023 Feb;24(2):e13520. doi: 10.1111/obr.13520. Epub 2022 Dec 1. Obes Rev. 2023. PMID: 36453081 Free PMC article. Review.

6

Deciphering the "obesity paradox" in the elderly: A systematic review and meta-analysis of sarcopenic obesity.

Liu C, Wong PY, Chung YL, Chow SK, Cheung WH, Law SW, Chan JCN, Wong RMY. Liu C, et al. Obes Rev. 2023 Feb;24(2):e13534. doi: 10.1111/obr.13534. Epub 2022 Nov 28. Obes Rev. 2023. PMID: 36443946 Review.

7

GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis.

Chadda KR, Cheng TS, Ong KK. Chadda KR, et al. Obes Rev. 2021 Jun;22(6):e13177. doi: 10.1111/obr.13177. Epub 2020 Dec 22. Obes Rev. 2021. PMID: 33354917 Review.

8

Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: A network meta-analysis of randomized clinical trials.

Alkhezi OS, Alahmed AA, Alfayez OM, Alzuman OA, Almutairi AR, Almohammed OA. Alkhezi OS, et al. Obes Rev. 2023 Mar;24(3):e13543. doi: 10.1111/obr.13543. Epub 2022 Dec 29. Obes Rev. 2023. PMID: 36579723 Review.

9

Obesity-related glomerulopathy: Current approaches and future perspectives.

Martínez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernández-García JC. Martínez-Montoro JI, et al. Obes Rev. 2022 Jul;23(7):e13450. doi: 10.1111/obr.13450. Epub 2022 Apr 1. Obes Rev. 2022. PMID: 35362662 Free PMC article. Review.

10

The incretin/glucagon system as a target for pharmacotherapy of obesity.

Del Prato S, Gallwitz B, Holst JJ, Meier JJ. Del Prato S, et al. Obes Rev. 2022 Feb;23(2):e13372. doi: 10.1111/obr.13372. Epub 2021 Oct 28. Obes Rev. 2022. PMID: 34713962 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,465 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,465 results

Results by year